Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Medicinal Chemistry|January 26, 2026
Structural Tuning of Vidofludimus for High-Efficacy NR4A AgonismJan Vietor, Romy Busch, Úrsula López-García, et al.ACS Medicinal Chemistry Letters|February 19, 2021
A New FXR Ligand Chemotype with Agonist/Antagonist SwitchMoritz Helmstädter, Jan Vietor, Jana Sommer, et al.Communications Chemistry|May 21, 2025
Structural and mechanistic profiling of Nurr1 modulation by vidofludimus enables structure-guided ligand designÚrsula López-García, Jan Vietor, Julian A Marschner, et al.Chemmedchem|June 14, 2026
Development of a Brain-Penetrant Nurr1 Agonist ToolJan Vietor, Tanja Stiller, Christian Gege, et al.Journal of Medicinal Chemistry|July 17, 2025
Carboxylic Acid Bioisosteres Boost Nurr1 Agonist SelectivityTanja Stiller, Christian Gege, Wael Saeb, et al.Journal of Medicinal Chemistry|May 1, 2023
Development of a Potent Nurr1 Agonist Tool for In Vivo ApplicationsJan Vietor, Christian Gege, Tanja Stiller, et al.Journal of Medicinal Chemistry|September 26, 2023
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand DihydroxyindoleMinh Sai, Jan Vietor, Moritz Kornmayer, et al.Journal of Medicinal Chemistry|September 11, 2024
Tuning RXR Modulators for PGC1α RecruitmentFelix Nawa, Minh Sai, Jan Vietor, et al.Pageof 1